Erectile dysfunction following radiation therapy
Methodology & AI Transparency ⓘ
Erectile dysfunction following radiation therapy Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Erectile dysfunction following radiation therapy is an ICD-10-CM indexed diagnosis (N52.35) within Men's Health, Testosterone & Sexual Function.
- 2 Real-world patient consensus: Mapped to Men's Health, Testosterone & Sexual Function under ICD-10-CM N52.35 for Erectile dysfunction following radiation therapy clinical workups.
- 3 Typical cash cost range: Primary evaluation for Erectile dysfunction following radiation therapy incorporates two fasting morning in Erectile dysfunction following radiation therapy (N52.35: LC-MS/MS testosterone assays) and symptom diary review.
- 4 Top reported side effects / signs: Follow-up benchmark in Erectile dysfunction following radiation therapy: maintaining Hematocrit & Total in Erectile dysfunction following radiation therapy (N52.35: PSA) within Hct < 50%; age-appropriate PSA (N52.35).
Ask our AI Specialists anything about Erectile dysfunction following radiation therapy
What Is Erectile dysfunction following radiation therapy?
Erectile dysfunction following radiation therapy is an ICD-10-CM indexed diagnosis (N52.35) within Men's Health, Testosterone & Sexual Function. Clinical evaluation centers on two fasting morning in Erectile dysfunction following radiation therapy (N52.35: LC-MS/MS testosterone assays) alongside serial Hematocrit & Total in Erectile dysfunction following radiation therapy (N52.35: PSA) tracking (Hct < 50%; age-appropriate PSA (N52.35)) to guide individualized care.
Pathophysiology, Underlying Causes & Clinical Presentation
Underlying Erectile dysfunction following radiation therapy (code N52.35) is primary testicular Leydig in Erectile dysfunction following radiation therapy (N52.35: cell insufficiency or), which Men's Health, Testosterone & Sexual Function clinicians address while surveilling Hematocrit & Total in Erectile dysfunction following radiation therapy (N52.35: PSA) (Hct < 50%; age-appropriate PSA (N52.35)).
Common Symptoms & Clinical Signs
- • Presentation of Erectile dysfunction following radiation therapy (N52.35): loss of lean in Erectile dysfunction following radiation therapy (N52.35: muscle recovery, rising)
- • Secondary Erectile dysfunction following radiation therapy clinical sign: blunted motivation, depressed in Erectile dysfunction following radiation therapy (N52.35: mood, or declining)
- • Symptom flares in Erectile dysfunction following radiation therapy correlating with Hematocrit & Total in Erectile dysfunction following radiation therapy (N52.35: PSA) deviation outside Hct < 50%; age-appropriate PSA (N52.35)
- • Functional men's health & trt impact requiring two fasting morning in Erectile dysfunction following radiation therapy (N52.35: LC-MS/MS testosterone assays) evaluation (N52.35)
Erectile dysfunction following radiation therapy Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | N52.35 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Men's Health, Testosterone & Sexual Function | NLM Clinical Tables |
| Diagnostic / Lab Marker: Hematocrit & Total in Erectile dysfunction following radiation therapy (N52.35: PSA) | Hct < 50%; age-appropriate PSA (N52.35) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Ultrasensitive Estradiol & in Erectile dysfunction following radiation therapy (N52.35: ApoB) | E2 20–38 pg/mL; ApoB < 80 mg/dL (N52.35) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Morning Total & in Erectile dysfunction following radiation therapy (N52.35: Free Testosterone (2x) | Total 500–900 ng/dL; Free 110–210 pg/mL (N52.35) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Erectile dysfunction following radiation therapy
Treatment selection for Erectile dysfunction following radiation therapy depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Erectile dysfunction following radiation therapy)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Testosterone Therapy for Late-Onset Hypogonadism Improves Erectile: What a 1,458-Participant Study Found TTh achieved a significant improvement in the IIEF-EFD score of hypogonadal men compared with placebo, especially in those who received testosterone gel, were treated for over 30 weeks, and had no comorbidities. Urologia internationalis • 2022-01-15 • Meta-Analysis | N = 1,458 | 99/100 | PMID 34856556 ↗ |
| New Insights on Depressive Syndromes in Men With Hypogonadism in the TRAVERSE Trial: Response to: What a 2,643-Participant Study Found Depressive symptoms are common in middle-aged and older men with hypogonadism but LG-PDD is uncommon. The Journal of clinical endocrinology and metabolism • 2024-06-17 • Randomized Controlled Trial | N = 2,643 | 96/100 | PMID 38205962 ↗ |
| Combination Therapies vs. Single-drug treatment: Which Works Better for Erectile Dysfunction? A total of 44 studies included 3853 men with a mean (SD) age of 55.8 (11.9) years. JAMA network open • 2021-02-01 • Meta-Analysis | N = 3,853 | 94/100 | PMID 33599772 ↗ |
| New Insights on Monotherapies and Combination Therapy of Tamsulosin and Tadalafil for Treating: What a 1,531-Participant Study Found Tadalafil combined with tamsulosin was more effective in the treatment of male LUTS/BPH, with or without ED, on the improvement of total IPSS, QoL, and Qmax. Urologia internationalis • 2024-01-15 • Meta-Analysis | N = 1,531 | 94/100 | PMID 38081154 ↗ |
| New Insights on Benefits and safety of Combination Comprising Tamsulosin and PDE5-Is, Relative to: What a 1,144-Participant Study Found However, therapy discontinuation due to pain and AEs did not increase with increase in AEs. American journal of men's health • 2020-01-15 • Meta-Analysis | N = 1,144 | 94/100 | PMID 33342335 ↗ |
Erectile dysfunction following radiation therapy Patient Community & “People Like Me” Threads
Filter Erectile dysfunction following radiation therapy community threads and patient logs by age, biological sex, dosage, and treatment duration.